Provided by Tiger Trade Technology Pte. Ltd.

LUYE PHARMA

1.895
+0.0703.84%
Volume:23.19M
Turnover:43.41M
Market Cap:7.57B
PE:10.22
High:1.895
Open:1.815
Low:1.815
Close:1.825
52wk High:3.690
52wk Low:1.690
Shares:4.00B
HK Float Shares:4.00B
Volume Ratio:1.04
T/O Rate:0.58%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.186
ROE:4.27%
ROA:2.18%
PB:0.42
PE(LYR):10.22
PS:1.06

Loading ...

Shandong Boan Biotech licenses U.S. rights to dulaglutide biosimilar BA5101 to partner

Reuters
·
Jun 11

Luye Pharma Completes $180 Million Convertible Bond Sale

MT Newswires Live
·
Jun 11

LUYE PHARMA Successfully Issues $180 Million Convertible Notes Due 2031

Stock News
·
Jun 11

Luye Pharma finalises US$180 million 5.25% convertible bond issue maturing 2031

Bulletin Express
·
Jun 11

Hong Kong Stocks Extend Losses Amid Middle East Flare-Up; Luye Pharma Proposes Debt Offering

MT Newswires Live
·
Jun 04

Hong Kong Market Midday Update: Hang Seng Index Down 1.4% as Semiconductor Sector Defies Broader Decline

Stock News
·
Jun 04

Luye Pharma Plans $180 Million Convertible Bond Sale, Bond Buyback

MT Newswires Live
·
Jun 04

FTSE China 50 Index Rebalance Adds GigaDevice, Pony.ai and WeRide Enter Southbound Stock Connect

Stock News
·
Jun 04

Luye Pharma to Repurchase 2028 Convertible Bonds at 103.13% and Issue New US$180 Million 5.25% CBs Due 2031

Bulletin Express
·
Jun 04

Luye Pharma - Proposed Concurrent Repurchase of US$180 Mln 6.25 per Cent. Convertible Bonds Due 2028

THOMSON REUTERS
·
Jun 04

Luye Pharma to Repurchase US$180.00 million 2028 CBs and Launch New USD Convertible Issue

Bulletin Express
·
Jun 03

LUYE PHARMA Announces Concurrent Tender Offer for $180 Million 2028 Convertible Notes and Proposed New USD-Denominated Convertible Bond Issuance

Stock News
·
Jun 03

Luye Pharma plans USD-denominated convertible bond issue alongside repurchase of US$ 180 million 6.25% convertibles due 2028

Reuters
·
Jun 03

Luye Pharma Schedules 26 June 2026 AGM; Proposes Director Re-elections, 20% Issuance Mandate and 10% Share Buyback

Bulletin Express
·
May 29

Luye Pharma announces annual general meeting

Reuters
·
May 29

Shandong Boan Bio submits US FDA BLA for two denosumab biosimilars

Reuters
·
May 29

Shandong Boan Biotechnology announces annual shareholder meeting

Reuters
·
May 27

Shandong Boan Biotechnology launches share buyback program worth up to HK$ 200 million

Reuters
·
May 13

Luye Pharma Reports Stable Share Capital and No Equity Movements in April 2026

Bulletin Express
·
May 07

Luye Pharma Releases 2025 ESG Report: Governance Upgrades, Emissions Rise on Higher Steam Consumption

Bulletin Express
·
Apr 29